Results 81 to 90 of about 30,678 (179)

The origins of Made in Spain fashion. The competitive advantage of the textile, apparel and footwear districts since the Golden Age [PDF]

open access: yes
This paper explores the sources of competitive advantage of the Spanish export industrial districts that specialised in textile, apparel and footwear products.
Jordi Catalan, Ramon Ramon-Munoz
core   +1 more source

Institutionalism Ancient, Old and New: A Historical Perspective on Institutions and Uneven Development [PDF]

open access: yes
institutions, structural change, uneven development, ancient institutional ...
Reinert, Erik S.
core  

The national depositor preference law [PDF]

open access: yes
A critical analysis of the probable effects of national depositor preference--a provision of the Omnibus Budget Reconciliation Act of 1993--showing that although the FDIC may experience some cost savings in the short term, the long-term benefits are ...
James B. Thomson
core  

Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort. [PDF]

open access: yesCancers (Basel), 2023
Trédan O   +21 more
europepmc   +1 more source

Linking the NETSARC+ National Sarcoma Database With the SNDS to Evaluate Adjuvant and/or Neoadjuvant Therapy: Report on the Linkage Process and Result (Health Data Hub's DEEPSARC Pilot Project). [PDF]

open access: yesFundam Clin Pharmacol
Drezen E   +12 more
europepmc   +1 more source

Seabirds shaped the expansion of pre-Inca society in Peru. [PDF]

open access: yesPLoS One
Bongers JL   +5 more
europepmc   +1 more source

CpoS-Inc interactions facilitate host cell modulation during <i>Chlamydia trachomatis</i> infection. [PDF]

open access: yesInfect Immun
Tijerina X   +6 more
europepmc   +1 more source

Contribution of Life-Course Socioeconomic Position to Later-Life Brain Volumes in US Hispanic/Latino Adults. [PDF]

open access: yesNeurology
Filigrana P   +14 more
europepmc   +1 more source

Durvalumab combined with weekly carboplatin/paclitaxel as first-line treatment of patients with recurrent and/or metastatic HNSCC not eligible for cisplatin-based chemotherapies: results of the multicenter prospective study FRAIL-IMMUNE. [PDF]

open access: yesESMO Open
Fayette J   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy